Unitedhealth Group INC Form 4 insider transactions
NYSE
Director Timothy Flynn reported acquiring 36 shares of UnitedHealth Group common stock as dividend equivalents and disposing of 2,000 shares held indirectly through a trust.
NYSE
Form 4: Michele J. Hooper Reports Acquisition of UnitedHealth Group Stock Through Dividend Equivalents
Director Michele J. Hooper acquired 155 shares of UnitedHealth Group common stock through dividend equivalents, increasing her direct holdings to 39,168 shares.
NYSE
Director Paul R. Garcia reports a transaction involving UnitedHealth Group common stock, including the acquisition of dividend equivalents.
NYSE
Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock due to dividend equivalents.
NYSE
Andrew Witty, CEO of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents and disposal of common stock.
NYSE
Stephen J. Hemsley, a director at UnitedHealth Group, executed multiple transactions involving the exercise of non-qualified stock options and the subsequent disposition of shares to cover tax obligations on June 14, 2024.
NYSE
Heather Cianfrocco, Chief Executive Officer of Optum, reports disposing of UnitedHealth Group (UNH) common stock to cover tax obligations.
NYSE
EVP & Chief People Officer of UnitedHealth Group, Erin McSweeney, reports a transaction involving common stock on June 7, 2024.
NYSE
Brian R. Thompson, CEO of UnitedHealthcare, reports a disposition of common stock to cover tax obligations.
NYSE
Director Stephen Hemsley reported a gift of UnitedHealth Group shares and the satisfaction of an annuity payment through share distribution.
NYSE
Heather Cianfrocco, Chief Executive Officer of Optum, reports the disposal of UnitedHealth Group common stock to cover tax obligations.
NYSE
John F. Rex, President & CFO of UnitedHealth Group, reports the acquisition of common stock and non-qualified stock options.
NYSE
Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition of common stock and non-qualified stock options in UnitedHealth Group.
NYSE
Director Timothy Patrick Flynn reports acquisition of UnitedHealth Group common stock and deferred stock units.
NYSE
Director Valerie Montgomery Rice acquired 192 shares of UnitedHealth Group common stock as part of her quarterly compensation for serving on the board.
NYSE
Director Charles D. Baker reports acquisition of deferred stock units as part of quarterly compensation for service on the UnitedHealth Group Board.
NYSE
Director Paul R. Garcia reports changes in beneficial ownership of UnitedHealth Group stock due to quarterly compensation and correction of previously misreported holdings.
NYSE
Director Kristen Gil reports acquisition of UnitedHealth Group common stock and deferred stock units as part of quarterly compensation.
NYSE
Director Frederick William McNabb III acquired 196 deferred stock units of UnitedHealth Group on April 1, 2024, as part of his quarterly compensation for board service.
NYSE
Director John H. Noseworthy acquired 192 shares of UnitedHealth Group common stock as part of his quarterly compensation for serving on the board.
NYSE
Director Michele J. Hooper reports acquiring 115 deferred stock units of UnitedHealth Group on April 1, 2024, as part of director compensation.
NYSE
Stephen J. Hemsley, a director at UnitedHealth Group, reported changes in his beneficial ownership of company stock due to the acquisition of deferred stock units.
NYSE
Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports the acquisition of common stock through dividend equivalents paid on restricted stock units.
NYSE
Form 4: UnitedHealth Group EVP Rupert Bondy Reports Acquisition of Common Stock Through Dividend Equivalents
Rupert M. Bondy, EVP & Chief Legal Officer of UnitedHealth Group, reports the acquisition of 21.579 shares of common stock due to dividend equivalents paid on restricted stock units.
NYSE
Director Stephen J. Hemsley reports acquisition of 24 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.
NYSE
John H. Noseworthy, a director at UnitedHealth Group, acquired 19 shares of common stock through dividend equivalents on vested deferred stock units.
NYSE
Frederick William McNabb III, a director at UnitedHealth Group, acquired 24 shares of common stock through dividend equivalents on March 19, 2024.
NYSE
EVP and Chief Financial Officer of UnitedHealth Group, John F. Rex, reports acquisition and disposal of common stock and dividend equivalents.
NYSE
Erin McSweeney, EVP & Chief People Officer of UnitedHealth Group, reports the acquisition and disposal of common stock and dividend equivalents related to restricted stock units.
NYSE
Director Kristen Gil reported the acquisition of dividend equivalents related to vested deferred stock units in UnitedHealth Group.